All entries for: Alembic Pharmaceuticals Inc.

July 31, 2025

Alembic Pharmaceuticals Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of pachyonychia congenita

Disease Area: Rare Diseases
Scroll to Top